Intestinal absorption of ribavirin is preferentially mediated by the Na+-nucleoside purine (N1) transporter

被引：78

作者：

Patil, SD

Ngo, LY

Glue, P

Unadkat, JD

机构：

[1] Univ Washington, Sch Pharm, Dept Pharmaceut, Seattle, WA 98195 USA

[2] Schering Plough Corp, Res Inst, Kenilworth, NJ 07033 USA

来源：

PHARMACEUTICAL RESEARCH | 1998年 / 15卷 / 06期

关键词：

ribavirin; Na+-nucleoside transport; brush border membrane vesicles; human intestine;

D O I：

10.1023/A:1011945103455

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

[No abstract available]

引用

页码：950 / 952

页数：3

共 14 条

[1]

BELT JA, 1993, ADV ENZYME REGUL, V33, P235

[2]

CASS CE, 1995, DRUG TRANSPORT ANTIM, P403

[3] Functional expression of human intestinal Na+-dependent and Na+-independent nucleoside transporters in Xenopus laevis oocytes [J].

Chandrasena, G ;

Giltay, R ;

Patil, SD ;

Bakken, A ;

Unadkat, JD .

BIOCHEMICAL PHARMACOLOGY, 1997, 53 (12) :1909-1918

[4] PHYSIOLOGICAL-PARAMETERS IN LABORATORY-ANIMALS AND HUMANS [J].

DAVIES, B ;

MORRIS, T .

PHARMACEUTICAL RESEARCH, 1993, 10 (07) :1093-1095

[5]

FERNANDEZ H, 1986, European Journal of Epidemiology, V2, P1, DOI 10.1007/BF00152711

[6] Nucleoside and nucleobase transport systems of mammalian cells [J].

Griffith, DA ;

Jarvis, SM .

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON BIOMEMBRANES, 1996, 1286 (03) :153-181

[7] EFFECTS OF RIBAVIRIN ON RESPIRATORY SYNCYTIAL VIRUS INVITRO [J].

HRUSKA, JF ;

BERNSTEIN, JM ;

DOUGLAS, RG ;

HALL, CB .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 17 (05) :770-775

[8]

KAWANA F, 1985, ANTIVIR RES, P83

[9] RIBAVIRIN DISPOSITION IN HIGH-RISK PATIENTS FOR ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].

LASKIN, OL ;

LONGSTRETH, JA ;

HART, CC ;

SCAVUZZO, D ;

KALMAN, CM ;

CONNOR, JD ;

ROBERTS, RB .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (05) :546-555

[10] PHARMACOKINETICS AND LONG-TERM TOLERANCE TO RIBAVIRIN IN ASYMPTOMATIC PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS [J].

LERTORA, JJL ;

REGE, AB ;

LACOUR, JT ;

FERENCZ, N ;

GEORGE, WJ ;

VANDYKE, RB ;

AGRAWAL, KC ;

HYSLOP, NE .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 50 (04) :442-449

← 1 2 →